Pretreatment with PCSK9 inhibitor protects the brain against cardiac ischemia/reperfusion injury through a reduction of neuronal inflammation and amyloid beta aggregation
© 2019 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. Background Cardiac ischemic/reperfusion (I/R) injury leads to brain damage. A new antihyperlipidemic drug is aimed at inhibitingPCSK9 (proprotein convertase subtilisin/kexin type 9), a molecule first identifi...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Journal |
| Published: |
2019
|
| Subjects: | |
| Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85059900929&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/63721 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | Chiang Mai University |